BMJ  2004;329:133 (17 July), doi:10.1136/bmj.38153.491887.7C (published 5 July 2004)

Paper

Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom

, UK Colorectal Cancer Screening Pilot Group

Correspondence to: Professor R J C Steele, University Department of Surgery and Molecular Oncology, Ninewells Hospital, Dundee DD1 9SY r.j.c.steele{at}dundee.ac.uk

Objective To assess the feasibility of introducing into the UK's NHS a national screening programme for colorectal cancer based on faecal occult blood testing.

Design Demonstration pilot.

Setting Two English health authorities and three Scottish health boards.

Participants People aged 50-69 years.

Results 478 250 residents of the pilot areas were invited to take part in the screening programme. Uptake (the proportion in whom a final faecal occult blood test result was available) was 56.8% (n = 271 646). The overall rate of a positive test result was 1.9% and the rate for detecting cancer was 1.62 per 1000 people screened. Both these values were higher in Scotland than in England, higher in men than in women, and increased with age. The positive predictive value was 10.9% for cancer and 35.0% for adenoma. 552 cancers were detected by screening; 92 (16.6%) were polyp cancers. 48% of all screen detected cancers were Dukes's stage A, and 1% had metastasised at the time of diagnosis.

Conclusions Screening for colorectal cancer by testing for faecal occult blood is feasible within the context of the United Kingdom's NHS. Screening should lead to a reduction in deaths from colorectal cancer in the population offered screening.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design
Nea Malila, Tiina Oivanen, Outi Malminiemi, and Matti Hakama
BMJ 2008 337: a2261. [Abstract] [Full Text] [PDF]

Pilot of bowel cancer screening shows lower uptake in second round
Roger Dobson
BMJ 2007 335: 1115. [Extract] [Full Text] [PDF]

Colorectal cancer in primary care
David Weller
BMJ 2006 333: 54-55. [Extract] [Full Text] [PDF]

The NHS could offer screening for colorectal cancer
BMJ 2004 329: 0. [Full Text] [PDF]

New treatments for colon cancer
Maurice Slevin and Sarah Payne
BMJ 2004 329: 124-126. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Steele, R J C, McClements, P L, Libby, G, Black, R, Morton, C, Birrell, J, Mowat, N A G, Wilson, J A, Kenicer, M, Carey, F A, Fraser, C G (2009). Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 58: 530-535 [Abstract] [Full text]  
  • Parkin, D M, Tappenden, P, Olsen, A H, Patnick, J, Sasieni, P (2008). Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen 15: 163-174 [Abstract] [Full text]  
  • van Rijn, A. F., van Rossum, L. G. M., Deutekom, M., Laheij, R. J. F., Fockens, P., Bossuyt, P. M. M., Dekker, E., Jansen, J. B. M. J. (2008). Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. J Public Health (Oxf) 30: 461-465 [Abstract] [Full text]  
  • Malila, N., Oivanen, T., Malminiemi, O., Hakama, M. (2008). Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 337: a2261-a2261 [Abstract] [Full text]  
  • Robb, K. A, Power, E., Atkin, W., Wardle, J. (2008). Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen 15: 130-136 [Abstract] [Full text]  
  • Goulard, H., Boussac-Zarebska, M., Ancelle-Park, R., Bloch, J. (2008). French colorectal cancer screening pilot programme: results of the first round. J Med Screen 15: 143-148 [Abstract] [Full text]  
  • Fraser, C G, Mathew, C M, McKay, K, Carey, F A, Steele, R J C (2008). Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut 57: 1256-1260 [Abstract] [Full text]  
  • Trevena, L. J, Irwig, L., Barratt, A. (2008). Randomized trial of a self-administered decision aid for colorectal cancer screening. J Med Screen 15: 76-82 [Abstract] [Full text]  
  • Rodger, J, Steele, R J C (2008). Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. J Med Screen 15: 105-107 [Abstract] [Full text]  
  • Denis, B., Ruetsch, M., Strentz, P., Vogel, J. Y., Guth, F., Boyaval, J. M., Pagnon, X., Ebelin, J. F., Gendre, I., Perrin, P. (2007). Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 56: 1579-1584 [Abstract] [Full text]  
  • Fraser, C. G, Mathew, C. M, Mowat, N A. G, Wilson, J. A, Carey, F. A, Steele, R. J C (2007). Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach. Gut 56: 1415-1418 [Abstract] [Full text]  
  • Zarychanski, R. MD, Chen, Y. PhD, Bernstein, C. N. MD, Hebert, P. C. MD MHSc (2007). Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 177: 593-597 [Abstract] [Full text]  
  • Smellie, W S A, Hampton, K K, Bowlees, R, Martin, S C, Shaw, N, Hoffman, J, Ng, J P, Mackenzie, S M, van Heyningen, C (2007). Best practice in primary care pathology: review 8. J. Clin. Pathol. 60: 740-748 [Abstract] [Full text]  
  • Tappenden, P., Chilcott, J., Eggington, S., Sakai, H., Karnon, J., Patnick, J. (2007). Option appraisal of population-based colorectal cancer screening programmes in England. Gut 56: 677-684 [Abstract] [Full text]  
  • Mai, P. L., Sullivan-Halley, J., Ursin, G., Stram, D. O., Deapen, D., Villaluna, D., Horn-Ross, P. L., Clarke, C. A., Reynolds, P., Ross, R. K., West, D. W., Anton-Culver, H., Ziogas, A., Bernstein, L. (2007). Physical Activity and Colon Cancer Risk among Women in the California Teachers Study. Cancer Epidemiol. Biomarkers Prev. 16: 517-525 [Abstract] [Full text]  
  • Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full text]  
  • (2006). Population screening for colorectal cancer. DTB 44: 65-68 [Abstract] [Full text]  
  • Weller, D. (2006). Colorectal cancer in primary care. BMJ 333: 54-55 [Full text]  
  • Barrett, J., Jiwa, M., Rose, P., Hamilton, W. (2006). Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract 23: 15-19 [Abstract] [Full text]  
  • Conlin, A, Smith, G, Carey, F A, Wolf, C R, Steele, R J C (2005). The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 54: 1283-1286 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Without considering Oncological Terrain, cancer efficacious primary prevention and screening are not possible.
Sergio Stagnaro
bmj.com, 16 Jul 2004 [Full text]
Age range 50-69 is right
Dr Linda Garvican
bmj.com, 18 Jul 2004 [Full text]
Screening should reduce deaths - does it ?
Christoph Pechlaner
bmj.com, 21 Jul 2004 [Full text]
Possible biases when estimating the outcome of colorectal cancer screening
John Brodersen
bmj.com, 21 Jul 2004 [Full text]
"So do I have cancer, doctor?"
Jamie S Robertson
bmj.com, 22 Jul 2004 [Full text]
Screening for colorectal cancer
Ala Szczepura
bmj.com, 30 Jul 2004 [Full text]
Colour blindness may be of importance in screening for colorectal cancer.
John L Campbell
bmj.com, 3 Sep 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ